| Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program M Janin, V Ortiz-Barahona, MC de Moura, A Martínez-Cardús, ... Acta neuropathologica 138, 1053-1074, 2019 | 123 | 2019 |
| Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer M Ensenyat-Mendez, P Llinàs-Arias, JIJ Orozco, S Íñiguez-Muñoz, ... Frontiers in oncology 11, 681476, 2021 | 96 | 2021 |
| Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update P Llinas-Arias, M Esteller Open biology 7 (9), 170152, 2017 | 93 | 2017 |
| Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer L Piqué, A Martinez de Paz, D Piñeyro, A Martínez-Cardús, ... Oncogene 38 (45), 7106-7112, 2019 | 54 | 2019 |
| Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer M Rosselló-Tortella, P Llinàs-Arias, Y Sakaguchi, K Miyauchi, V Davalos, ... Proceedings of the National Academy of Sciences 117 (34), 20785-20793, 2020 | 39 | 2020 |
| Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer M Pérez-Salvia, L Simó-Riudalbas, P Llinàs-Arias, L Roa, F Setien, ... Oncotarget 8 (31), 51621, 2017 | 30 | 2017 |
| Epigenetic loss of the endoplasmic reticulum–associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming P Llinàs-Arias, M Rosselló-Tortella, P López-Serra, M Pérez-Salvia, ... JCI insight 4 (8), 2019 | 23 | 2019 |
| Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer S Belhadj, C Moutinho, P Mur, F Setien, P Llinàs-Arias, M Pérez-Salvia, ... Cancer Letters 447, 86-92, 2019 | 17 | 2019 |
| In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma M Pérez-Salvia, E Aldaba, Y Vara, M Fabre, C Ferrer, C Masdeu, A Zubia, ... Haematologica 103 (11), e537, 2018 | 16 | 2018 |
| Epigenetic regulation of immunotherapy response in triple-negative breast cancer P Llinàs-Arias, S Íñiguez-Muñoz, K McCann, L Voorwerk, JIJ Orozco, ... Cancers 13 (16), 4139, 2021 | 12 | 2021 |
| MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex P Llabata, M Torres-Diz, A Gomez, L Tomas-Daza, OA Romero, ... Proceedings of the National Academy of Sciences 118 (37), e2024824118, 2021 | 10 | 2021 |
| Raltitrexed-modified gold and silver nanoparticles for targeted cancer therapy: cytotoxicity behavior in vitro on A549 and HCT-116 human cancer cells J Morey, P Llinás, A Bueno-Costa, AJ León, MN Piña Materials 14 (3), 534, 2021 | 10 | 2021 |
| Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology B Sesé, M Ensenyat-Mendez, S Iñiguez, P Llinàs-Arias, DM Marzese Clinical epigenetics 13 (1), 150, 2021 | 9 | 2021 |
| Genetics and epigenetics of leukemia and lymphoma: From knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute M Parra, MJ Baptista, E Genescà, P Llinàs‐Arias, M Esteller Hematological Oncology 38 (4), 432-438, 2020 | 8 | 2020 |
| Glioblastoma embryonic-like stem cells exhibit immune-evasive phenotype B Sesé, S Íñiguez-Muñoz, M Ensenyat-Mendez, P Llinàs-Arias, G Ramis, ... Cancers 14 (9), 2070, 2022 | 7 | 2022 |
| New bicistronic TALENs greatly improve genome editing JM Martín‐Fernández, A Fleischer, S Vallejo‐Diez, E Palomino, ... Current Protocols in Stem Cell Biology 52 (1), e104, 2020 | 5 | 2020 |
| Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors P Llinàs-Arias, M Ensenyat-Mendez, S Íñiguez-Muñoz, JIJ Orozco, ... Molecular cancer 22 (1), 190, 2023 | 2 | 2023 |
| Epigenetic profiles of triple-negative breast cancers of African American and White females M Ensenyat-Mendez, M Solivellas-Pieras, P Llinàs-Arias, ... JAMA network open 6 (10), e2335821-e2335821, 2023 | 2 | 2023 |
| 3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer P Llinàs-Arias, M Ensenyat-Méndez, JIJ Orozco, S Íñiguez-Muñoz, ... BMC genomic data 24 (1), 61, 2023 | 1 | 2023 |
| Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer M Ensenyat-Mendez, JIJ Orozco, P Llinàs-Arias, S Íñiguez-Muñoz, ... Communications medicine 3 (1), 93, 2023 | 1 | 2023 |
